IHL 0.00% 4.1¢ incannex healthcare limited

Ann: IHL-42X positive phase 2 clinical trial results, page-60

  1. 885 Posts.
    lightbulb Created with Sketch. 467
    I don't think the market is recognising how significant the 44% reduction is.

    Reminder that in the 2019 AGM, IIRC the Sudmeister himself said anything above 10-15% is "clinically significant" and 30% is a "mind boggling" number.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.